|
|
Integrated Biopharma Inc (INBP) |
|
|
|
INBP's Net Income Growth by Quarter and Year
Integrated Biopharma Inc's Net Income results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
|
INBP Net Income (in millions $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
IV Quarter |
June |
-
|
1.49
|
4.51
|
1.90
|
III Quarter |
March |
-
|
0.80
|
1.24
|
0.94
|
II Quarter |
December |
-
|
1.03
|
1.22
|
0.96
|
I Quarter |
September |
-0.04
|
0.52
|
1.04
|
0.31
|
FY |
|
-0.04
|
3.84
|
8.01
|
4.11
|
INBP Net Income first quarter 2023 Y/Y Growth Comment |
Integrated Biopharma Inc in the first quarter 2023 recorded net loss of $ -0.04 millions.
According to the results reported in the first quarter 2023, Integrated Biopharma Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Integrated Biopharma Inc' s Net Income no change of % ranks overall at the positon no. in the first quarter 2023.
|
INBP Net Income ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
June |
- |
-66.96 % |
137.37 % |
427.78 % |
III Quarter |
March |
- |
-35.48 % |
31.91 % |
2.17 % |
II Quarter |
December |
- |
-15.57 % |
27.08 % |
284 % |
I Quarter |
September |
- |
-50 % |
235.48 % |
93.75 % |
FY |
|
- |
-52.06 % |
94.89 % |
143.2 % |
INBP Net Income (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
June |
- |
86.25 % |
263.71 % |
102.13 % |
III Quarter |
March |
- |
-22.33 % |
1.64 % |
-2.08 % |
II Quarter |
December |
- |
98.08 % |
17.31 % |
209.68 % |
I Quarter |
September |
- |
-88.47 % |
-45.26 % |
-13.89 % |
FY (Year on Year) |
|
- |
-52.06 % |
94.89 % |
143.2 % |
Net Income Y/Y Growth Statistics |
High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
|
Net Income Y/Y Growth Statistics |
High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
|
Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Integrated Biopharma Inc's Q/Q Net Income Growth
Net Income Q/Q Growth Statistics |
High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
INBP's I. Quarter Q/Q Net Income Comment |
I. Quarter 2023 accomplishment of -0.04 millions by Integrated Biopharma Inc look even less good considering the net loss 1.49 millions in the previous quarter.
Within Major Pharmaceutical Preparations industry Integrated Biopharma Inc achieved highest sequential Net Income growth. While Integrated Biopharma Inc's Net Income growth quarter on quarter, overall rank is . |
|
|
Net Income Q/Q Growth Statistics |
High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
INBP's I. Quarter Q/Q Net Income Comment |
I. Quarter 2023 accomplishment of -0.04 millions by Integrated Biopharma Inc appear even more unfavourable considering the 1.49 millions net loss in the previous quarter.
Within Major Pharmaceutical Preparations industry Integrated Biopharma Inc achieved highest sequential Net Income growth. While Integrated Biopharma Inc's Net Income growth quarter on quarter, overall rank is . |
|
Integrated Biopharma Inc's 12 Months Net Income Growth Year on Year
Net Income TTM Growth |
12 Months Ending (Sep 30 2022) |
12 Months Ending (Jun 30 2022) |
12 Months Ending (Mar 31 2022) |
12 Months Ending (Dec 31 2021) |
12 Months Ending (Sep 30 2021) |
Cumulative Net Income 12 Months Ending |
$ 3.29 |
$ 3.84 |
$ 6.85 |
$ 7.30 |
$ 7.49 |
Y / Y Net Income Growth (TTM) |
-56.1 % |
-52.1 % |
26.71 % |
42.98 % |
54.81 % |
Year on Year Net Income Growth Overall
Ranking |
| | |